Technical Trend Shift and Price Movement
Suraksha Diagnostic’s current price stands at ₹256.10, down 1.29% from the previous close of ₹259.45. The stock’s intraday range has been relatively tight, with a low of ₹253.95 and a high of ₹264.30, reflecting cautious trading sentiment. Over the past week, the stock has declined by 4.26%, slightly outperforming the Sensex’s 4.98% fall, but the one-month return of -10.14% lags behind the Sensex’s -9.13%, indicating underperformance in the near term.
The 52-week high of ₹353.65 and low of ₹227.95 highlight a wide trading band, but the current price remains closer to the lower end, suggesting limited upside momentum and persistent bearish pressure.
MACD and Momentum Indicators
The Moving Average Convergence Divergence (MACD) indicator on the weekly chart is firmly bearish, signalling that the short-term momentum is weakening relative to the longer-term trend. The monthly MACD reading is inconclusive, lacking a clear directional bias, which suggests that while short-term momentum is deteriorating, the longer-term trend remains uncertain.
Relative Strength Index (RSI) readings on both weekly and monthly timeframes show no definitive signals, hovering in neutral zones without indicating oversold or overbought conditions. This lack of RSI extremes implies that the stock is not yet at a technical inflection point where a reversal might be imminent.
Moving Averages and Bollinger Bands
Daily moving averages have turned bearish, with the stock price trading below key averages, reinforcing the downtrend. The weekly Bollinger Bands also reflect bearishness, with the price gravitating towards the lower band, indicating increased volatility and selling pressure. The absence of a monthly Bollinger Band signal leaves the longer-term volatility picture less clear but does not contradict the prevailing bearish sentiment.
Additional Technical Signals
The Know Sure Thing (KST) indicator on the weekly chart remains mildly bullish, suggesting some underlying positive momentum that could provide limited support. However, this is overshadowed by the Dow Theory’s monthly bearish trend and the lack of trend confirmation from On-Balance Volume (OBV) on both weekly and monthly charts, which show no clear directional bias in volume flow.
While markets shift, this one's charging ahead! This Micro Cap from Aquaculture shows the strongest momentum signals in current conditions. Don't miss out on this ride!
- - Strongest current momentum
- - Market-cycle outperformer
- - Aquaculture sector strength
Comparative Performance and Market Context
Examining Suraksha Diagnostic’s returns relative to the Sensex reveals a mixed picture. Year-to-date, the stock has declined 4.51%, outperforming the Sensex’s sharper 10.78% fall, which may indicate some resilience amid broader market weakness. However, over the one-month horizon, the stock’s 10.14% loss exceeds the Sensex’s 9.13% drop, signalling recent underperformance.
Longer-term returns show modest gains, with a 0.39% increase over one year compared to the Sensex’s 2.71%. Data for three, five, and ten-year returns are not available for the stock, but the Sensex’s robust gains over these periods (28.58%, 49.70%, and 207.61% respectively) highlight the challenges faced by this micro-cap in matching broader market growth.
Mojo Score and Analyst Ratings
Suraksha Diagnostic currently holds a Mojo Score of 36.0, categorised as a Sell rating. This represents a downgrade from a previous Hold rating as of 11 August 2025, reflecting the deteriorating technical and fundamental outlook. The micro-cap status of the company adds to the risk profile, with limited liquidity and higher volatility compared to larger peers in the Healthcare Services sector.
Investors should note that the downgrade aligns with the bearish technical signals and the stock’s recent price weakness, suggesting caution in positioning for near-term gains.
Suraksha Diagnostic Ltd or something better? Our SwitchER feature analyzes this micro-cap Healthcare Services stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Outlook and Investor Considerations
Given the current technical landscape, Suraksha Diagnostic Ltd appears to be in a consolidation phase with a bearish bias. The weekly MACD and Bollinger Bands suggest that downward momentum may persist in the short term, while the absence of strong RSI signals indicates no immediate oversold conditions to prompt a rebound.
Investors should weigh the micro-cap risks, including lower liquidity and higher volatility, against the stock’s modest resilience relative to the broader market year-to-date. The downgrade in Mojo Grade to Sell further emphasises the need for caution.
For those seeking exposure to the Healthcare Services sector, it may be prudent to monitor technical developments closely or consider alternative stocks with stronger momentum and more favourable technical profiles.
Summary
Suraksha Diagnostic Ltd’s technical indicators have shifted decisively towards bearishness, with key signals such as the weekly MACD and daily moving averages confirming a downtrend. Price momentum has weakened, and the stock’s recent underperformance relative to the Sensex over one month adds to the cautious outlook. While some mild bullishness in the KST indicator offers limited support, the overall technical and fundamental picture suggests that investors should approach this micro-cap with prudence amid prevailing market uncertainties.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
